Esperance Pharmaceuticals has started Phase 1 clinical studies of a drug designed to seek and destroy cancer cells. The Baton Rouge-based biotech firm is testing EP-100 in patients with advanced solid…
Already an INSIDER? Sign in.
B.R. biotech firm starts clinical studies on cancer drug
